Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Advances in Treating Scleroderma Lung Disease

Keck School of Medicine of USC

L. Kobashigawa

EADV 2024 Insights: Eosinophilic Fasciitis

EADV 2024 Insights

F. Rongioletti

Defining the Molecular Natural History of Early and Progressive Pulm…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

N. Banovich

Challenges in ILD: Prediction With or Without Big Data

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Fingerlin

Update on the New ANA Classification System

Keck School of Medicine of USC

E. Taylor-Albert

Medical Marijuana in Rheumatology: Fact or Fiction?

Keck School of Medicine of USC

A. Wells

Panel Discussion Chaired by Dr. Weichart on Big Data and How to Move…

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Weichhart

Clinical Trials for Pulmonary Fibrotic Diseases

Temple Lung Center

G. Criner

Beyond Treatment Preventing Progressive Pulmonary Fibrosis

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

J. Kropski

Translational Medicine and Data-Driven Clinical Applications in ILDs

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

N. Rivera

Multidisciplinary ILD Case Discussions

UCLA Health

A. Chung, E. R. Volkmann, F. Abtin, G. Fishbein

Delayed Diagnosis of SSc-ILD With Progressive Pulmonary Fibrosis

The France Foundation

E. R. Volkmann

Co-Management of CTD-ILD: A Rheumatology and Pulmonology Perspective

West Virginia State Rheumatology Society

R. Aggarwal, D. Sullivan

Auto-Antibodies in IPF

WASOG - World Association of Sarcoidosis and Other Granulomatous Disorders

T. Plante-Bordeneuve

Pulmonary Involvement in Rheumatic Diseases: A Review

Brigham and Women's Hospital

P. Dellaripa

ACR Convergence 2023 Highlights: Myositis Pearls for Diagnosis and M…

Highlights from ACR Convergence 2023

L. Christopher-Stine

Recent Advances in SSc-ILD: Screening, Monitoring and Treatment

Elizabeth R. Volkmann

Rheumatic Disease and Pulmonary Disease: Pearls and Tips

Fifth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension

R. Keating

Rituximab vs. Tocilizumab for Scleroderma: Which is Better?

RheumNow

J. Pope